Press release
Rare Kidney Diseases Treatment Market Projected to Reach US$ 4.6 Billion by 2031, with a Compound Annual Growth Rate (CAGR) of 5.8%
The global rare kidney disease treatment market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 5.8% from 2023 to 2031, culminating in an estimated valuation of US$ 4.6 billion by the end of the forecast period.Market Dynamics
Collaborative interactions among clinicians, patients, industry representatives, regulatory agents, and government agencies are driving the expansion of complex illness demands.
Advancements in diagnosis and treatment methods are further fueling market growth.
Download a Sample for Highlights on Market Drivers and Challenges Affecting the Rare Kidney Diseases Treatment:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85247&utm_source=OpenPR_Ajay&utm_medium=OpenPR
Diagnostic Advancements
Next-generation sequencing techniques are expected to enhance diagnostic precision, unravel molecular disease mechanisms, simplify genetic counseling, and offer carrier testing opportunities.
Treatment Advancements
Advancements in renal replacement therapy and improved accessibility are prolonging patients' lives, albeit potentially impacting their quality of life.
Key Market Insights
The market was valued at US$ 2.91 billion in 2023.
Enzyme replacement therapy is anticipated to dominate the market by growing at a CAGR of 6.2% during the forecast period.
The United States and China are projected to experience significant demand growth, with CAGRs of 5.7% and 5.9% respectively.
Growth Drivers and Trends
Growing awareness and understanding of rare kidney diseases are expected to propel market growth.
Increased research efforts and knowledge dissemination contribute to market expansion.
Rising demand for efficient treatments and therapies is driving market growth.
Increasing incidences of kidney diseases, coupled with a growing elderly population, are significant growth drivers.
Get Customized Solution to Meet Your Research Requirements: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=85247&utm_source=OpenPR_Ajay&utm_medium=OpenPR
Regional Analysis
North America is poised to dominate the market, accounting for over 46% market share in 2023, with a projected CAGR of 5.6%.
Asia Pacific is expected to witness substantial growth, fueled by a large patient base and increasing awareness of rare urinary diseases.
Prominent Players
Several global and regional entities operate in the rare kidney diseases treatment market, including:
Calliditas Therapeutics AB
GSK plc
Aurinia Pharmaceuticals, Inc.
Amicus Therapeutics, Inc.
Shire (Takeda Pharmaceutical Company Limited)
Sanofi
Advicenne
Alexion Pharmaceuticals, Inc.
Horizon Therapeutics plc
Otsuka Pharmaceutical Co., Ltd.
Reata Pharmaceuticals, Inc.
Buy this Premium Research Report | Immediate Delivery Available at https://www.transparencymarketresearch.com/checkout.php?rep_id=85247<ype=S&utm_source=OpenPR_Ajay&utm_medium=OpenPR
Key Developments
Calliditas Therapeutics AB received marketing authorization from the European Commission for Kinpeygo, a treatment for primary immunoglobulin A (IgA) nephropathy.
Aurinia Pharmaceuticals, Inc. obtained FDA approval for LUPKYNIS, the first oral therapy approved for lupus nephritis.
Advicenne introduced Sibnayal in the United Kingdom for the treatment of distal renal tubular acidosis.
Key Segments
Drug Class: Enzyme Replacement Therapy, Monoclonal Antibodies, Others
Indication: Fabry Disease, Atypical Hemolytic Uremic Syndrome, Lupus Nephritis, Nephropathic Cystinosis, Others
Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales
Regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rare Kidney Diseases Treatment Market Projected to Reach US$ 4.6 Billion by 2031, with a Compound Annual Growth Rate (CAGR) of 5.8% here
News-ID: 3374467 • Views: …
More Releases from Transparency Market Research
Europe Insect Screen Market Poised for Steady Growth on the Back of Rising Healt …
The Europe Insect Screen Market continues to gain momentum, driven by heightened emphasis on public health, energy efficiency, and sustainable building solutions. Valued at US$ 285.4 Mn in 2024, the market is set to grow consistently and reach US$ 480.0 Mn by 2035, expanding at a CAGR of 5.0% during the forecast period.
Increasing focus on maintaining hygienic indoor environments, coupled with advancements in building technologies, is accelerating the adoption of…
Tennis Ball Machines Market to Reach USD 40.3 Million by 2035, Driven by Rising …
According to a new research report published by Transparency Market Research, the global tennis ball machines market was valued at US$ 27.4 Mn in 2024 and is projected to reach US$ 40.3 Mn by 2035, expanding at a CAGR of 3.4% from 2025 to 2035. The market is witnessing steady expansion driven by a surge in tennis participation, rising adoption of advanced training tools, and strong consumer preference for lightweight,…
Global Poultry Farming Equipment Market to Reach USD 6.7 Bn by 2034, Driven by A …
The global poultry industry is entering a new era of modernization as farms worldwide adopt advanced, automated equipment to meet soaring demand for poultry products. According to the latest market assessment, the global poultry farming equipment market was valued at US$ 4.1 Bn in 2023 and is projected to expand steadily at a CAGR of 4.5% from 2024 to 2034, reaching US$ 6.7 Bn by 2034. This growth is fueled…
Europe External Blinds Market Set to Reach USD 22.9 Billion by 2034, Driven by S …
The Europe External Blinds Market is positioned for steady growth over the next decade, with market value expected to rise from US$ 15.2 billion in 2023 to US$ 22.9 billion by 2034, expanding at a CAGR of 3.9% from 2024 to 2034. Increasing adoption of smart home solutions, rising environmental consciousness, and strong government regulations supporting energy efficiency are key factors contributing to this growth.
Introduction: External blinds have emerged as…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
